MIRM

Mirum Pharmaceuticals, Inc. - common stock (MIRM)

About Mirum Pharmaceuticals, Inc. - common stock (MIRM)

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Details

Daily high

$98.76

Daily low

$91.73

Price at open

52 Week High

$130.00

52 Week Low

$63.23

Market cap

6.0B

Dividend yield

Volume

714

Avg. volume

616,305

P/E ratio

-6.31

Mirum Pharmaceuticals, Inc. - common stock News